Radiolabelled monoclonal antibodies in clinical and surgical oncology: a review.
Panminerva Med. 1997 Mar;39(1):46-52
Radiolabelled monoclonal antibodies in clinical and surgical oncology: a review.
Biassoni L, D'Andrea V, Biancari F, Santoni F, Dibra A, De Antoni E.
Department of Nuclear Medicine, St. Bartholomew's Hospital, London, UK.
Over the past decade, the role of immunoscintigraphy using radiolabelled monoclonal antibodies has been steadily growing in clinical oncology, and in particular, in radioimmunotherapy and radioimmunoguided surgery for the treatment of primary, recurrent, and metastatic colorectal, ovarian, gastric, and prostate cancer. Herein, the authors review the requirements for successful tumour radioimmunodetection and related procedures.
Publication Types:
Review Review, Tutorial
PMID: 9175421 [PubMed - indexed for MEDLINE]